急性炎性疾病患者乳酸林格氏液液体动力学

doi:10.12092/j.issn.1009-2501.2019.04.010

中国临床药理学与治疗学 ›› 2019, Vol. 24 ›› Issue (4): 424-432.doi: 10.12092/j.issn.1009-2501.2019.04.010

急性炎性疾病患者乳酸林格氏液液体动力学

晓敏¹, 易声华^2,3, 朱烨柯^2,3, 单跃^2,3, 腾尹彤⁴, 滕文彬^2,3, 李玉红^2,3

¹温岭市第一人民医院麻醉科，温岭 317500，浙江； ²绍兴市人民医院医学研究中心，³麻醉科，绍兴 312000，浙江；⁴昆明理工大学医学院，昆明 690093，广西

收稿日期:2018-08-19 修回日期:2019-03-24 出版日期:2019-04-26 发布日期:2019-05-01
通讯作者: 李玉红，女，博士，主任医师，研究方向：围手术期液体治疗。 Tel：0575-88228660 E-mail：yuh_li@qq.com
作者简介:叶晓敏，男，本科，主治医师，研究方向：围手术期液体治疗。 Tel：13605864124 E-mail：yexiaoming123@126.com 易声华，共同第一作者，男，硕士，副主任医师，研究方向：围手术期液体治疗。 Tel：18957556727 E-mail：yi6626@126.com
基金资助:
浙江省科技厅动物平台项目（2017C37160）；浙江省医药卫生科技计划项目（2018KY173）；绍兴市科技局公益项目（2017B70038）

Volume kinetics of Ringer's lactate in acute inflammatory disease

YE Xiaomin¹, YI Shenghua ^2,3, ZHU Yeke ^2,3, CHAN Yue ^2,3, TENG Yitong ^2,3, TENG Wenbin ^2,3, LI Yuhong ^2,3

¹ Department of Anesthesiology, the First Wenlin People's Hospital, Wenlin 317500, Zhejiang, China; ²Medical Research Center, ³Department of Anesthesiology, Shaoxing People's Hospital, Shaoxing 312000, Zhejiang, China; ⁴Kunming University of Science and Technology, School of Medicine, Kunming 690093, Guangxi, China

Received:2018-08-19 Revised:2019-03-24 Online:2019-04-26 Published:2019-05-01

摘要/Abstract

摘要：

目的:探索炎性疾病患者的乳酸林格氏液（Ringer's lactate,RL）液体动力学特征以及炎性生物标记物是否可以作为协变量影响RL分布和排泄。方法:本研究为前瞻性队列研究。选择40例美国麻醉医师分级（ASA）I-II级，腹腔镜下择期胆囊切除术（胆囊炎组，n=20）或者腹腔镜下急诊阑尾切除术（阑尾炎组，n=20）。所有患者麻醉诱导前开始输注RL，按15 mL/kg，35 min内输毕。采用酶联免疫（enzyme-linked immunosorbent assay,ELISA）方法测定血浆炎症（TNF-α,IL-10和CRP）或者内皮损伤生物标记物（syndecan-1,SDC-1）；利用血红蛋白（Hb）稀释-时间曲线和尿量，使用Phoenix软件，采用非线性混合效应模型分析计算RL液体动力学参数和协变量的影响。结果:与胆囊炎组相比，阑尾炎组RL从组织间隙到血浆的转运速率常数（k21）显著降低（14×10-3min-1 versus 35×10-3min-1;P=0.012）。阑尾炎组C反应蛋白（CRP）升高［中位数38.1(1.8-143.6) μg/mL versus 1.3(0.1-159.0) μg/mL;P<0.001］；与清醒状态相比，麻醉期间（输液开始后30～45 min），液体从中央室中到外周室的转运速率常数（k12）显著增加（57×10-3min-1 versus 32×10-3min-1；P<0.01）。清除速率常数（k10）降低90%（0.6×10-3min-1 versus 5.3×10-3min-1;P<0.001）。无论在清醒状态还是麻醉状态下低血压均能降低液体清除；炎症或者内膜损伤的生物标记物不能作为显著影响RL液体动力学参数的协变量。结论:阑尾炎或者胆囊炎患者术前输入液体后“炎症反应的生物标记物”不是RL的液体动力学的协变量，但是两组患者中，全身麻醉期间输入液体的清除率下降。

关键词: 晶体液, 乳酸林格氏液, 人类, 炎症, 液体动力学

Abstract:

AIM: To explore the volume kinetics of Ringer's lactate (RL) in acute inflammatory disease and whether the inflammatory biomarker would be associated with altered distribution and elimination of RL. METHODS: In this prospective cohort study, we enrolled 40 ASA physical status I-II patients undergoing elective laparoscopic cholecystectomy (cholecystitis group, n=20) or emergency laparoscopic appendectomy (appendicitis group, n=20). All of the patients were infused RL (15 mL/kg) intravenously over 35 min, starting before the induction of general anesthesia. Plasma concentrations of inflammatory (tumor necrosis factor-α, interleukin-10, and C-reactive protein) and endothelial damage (syndecan-1, SDC-1) biomarkers were quantified by enzyme-linked immunosorbent assay (ELISA). The kinetics of RL and the effects of covariates were calculated by plasma dilution based on the dilution of hemoglobin-time curve, urinary excretion by using Phoenix software for mixed effects modeling. RESULTS:Compared with the cholecystitis group, the rate constant for fluid transfer from the peripheral fluid space to the central fluid space (k21) decreased significantly in the appendicitis group (14×10-3min-1 versus 35×10-3min-1; P=0.012), in whom higher plasma concentrations of C-reactive protein (CRP) were measured ［median: 38.1(1.8-143.6) μg/mL versus 1.3(0.1-159.0) μg/mL, P<0.001］. Compared with conscious period, ongoing anesthesia (duration: 30 min-45 min after beginning of infusion) increased the rate constant for fluid transfer from the plasma to the extravascular space (k12) significantly (57×10-3min-1 versus 32×10-3min-1), and decreased the elimination rate constant (k10: from 0.6×10-3min-1 to 5.3×10-3min-1; P<0.001). A lower mean arterial pressure was associated with reduced elimination, independent of conscious/anaesthetized state. However, no biomarkers for inflammation or endothelial damage were significantly associated covariates in the kinetic model. CONCLUSION: No association was found between the volume kinetics of Ringer's lactate and the degree of inflammation (as indicated by established biomarkers) in patients with cholecystitis or appendicitis. However, the rate of elimination was greatly retarded by general anesthesia in both groups.

Key words: crystalloid solutions, Ringer's lactate, humans, inflammation, volume kinetics

中图分类号:

R614：R969.1

叶晓敏, 易声华, 朱烨柯, 单跃, 腾尹彤, 滕文彬, 李玉红. 急性炎性疾病患者乳酸林格氏液液体动力学[J]. 中国临床药理学与治疗学, 2019, 24(4): 424-432.

YE Xiaomin, YI Shenghua, ZHU Yeke, CHAN Yue, TENG Yitong, TENG Wenbin, LI Yuhong. Volume kinetics of Ringer's lactate in acute inflammatory disease[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 424-432.

参考文献

［1］Hahn RG. Arterial pressure and the elimination of crystalloid fluid: a population-based study［J］. Anesth Analg, 2017, 124(6): 1824-1833.
［2］Zdolsek J, Li Y, Hahn RG. Detection of dehydration by using volume kinetics ［J］. Anesth Analg, 2012, 115(4): 814-822.
［3］Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy ［J］. Br J Anaesth, 2012, 108(3): 384-394.
［4］Kolsen-Petersen JA. The endothelial glycocalyx: the great luminal barrier ［J］. Acta Anaesthesiol Scand, 2015, 59(2): 137e9.
［5］Bashandy GMN. Implications of recent accumulating knowledge about endothelial glycocalyx on anesthetic management ［J］. J Anesth, 2015, 29(2): 269e78.
［6］王军会, 李玉红, 茹国美, 等. 成人与儿童乳酸林格氏液液体动力学的比较［J］. 中国临床药理学和治疗学, 2015, 20(8): 909-915.
［7］Li YH, Zhu HB, Zheng X, et al. Low doses of esmolol and phenylephrine act as diuretics during intravenous anesthesia ［J］. Crit Care, 2012, 16(1): R18.
［8］Atlas G, Li JK, Amin S, et al. Development and retrospective clinical assessment of a patient-specific closed-form integro-differential equation model of plasma dilution ［J］. Biomed Eng Comput Biol, 2017, 8: 1179597217730305.
［9］Hahn RG. Influences of red blood cell and platelet counts on the distribution and elimination of crystalloid fluid ［J］. Medicina, 2017, 53(4): 233-241.
［10］Rodhe P, Drobin D, Hahn RG, et al. Modelling of peripheral fluid accumulation after a crystalloid bolus in female volunteers-a mathematical study ［J］. Comput Math Methods Med, 2010, 11(4): 341-351.
［11］单跃, 郑晓铸, 李玉红, 等. 肾上腺素α1受体激动剂对妇科腹腔镜手术患者乳酸林格氏液的液体动力学影响［J］. 中华危重症学杂志, 2015, 8(2): 84-90.
［12］Hahn RG. Volume kinetics for infusion fluids ［J］. Anesthesiology, 2010, 113: 470e81.
［13］Owen JS, Fiedler-Kelly J. Introduction to population pharmacokinetic/ pharmacodynamic analysis with nonlinear mixed effects models. Hoboken, New Jersey: Wiley & Sons; 2014.
［14］Hahn RG, Lyons G. The half-life of infusion fluids: an educational review ［J］. Eur J Anaesthesiol, 2016, 33: 475e82.
［15］Li Y, Xiaozhu Z, Guomei R, et al. Effects of vasoactive drugs on crystalloid fluid kinetics in septic sheep ［J］. PLoS One 2017, 12: e0172361.
［16］Hahn RG, Gebck T. Fluid volume kinetics of dilutional hyponatremia; a shock syndrome revisited ［J］. Clinics, 2014, 69: 120e7.
［17］Nemme J, Hahn RG, Krizhanovskii C, et al. Minimal shedding of the glycocalyx layer during abdominal hysterectomy ［J］. BMC Anesthesiol, 2017, 17(1): 107.
［18］Li Y, Hahn RG, Hu Y, et al. Plasma and renal clearances of lactated Ringer's solution in pediatric and adult patients just before anesthesia is induced ［J］. Pediatr Anesth, 2009, 19(7): 682e7.
［19］Benias PC, Wells R, Sackey-Aboagye B, et al. Structure and distribution of an unrecognized interstitium in human tissues［J］. Sci Rep, 2018, 8(1): 4947.
［20］de Oliveira Machado SL, Bagatini MD, da Costa P, et al. Evaluation of mediators of oxidative stress and inflammation in patients with acute appendicitis［J］. Biomarkers, 2016, 21(6): 530-537.
［21］Hahn RG, Lindahl C, Drobin D. Volume kinetics of acetated Ringer's solution during experimental spinal anesthesia［J］. Acta Anaesthesiol Scand, 2011, 55(8): 987e94.

[1]	廖梦玲, 汪艳, 罗静, 王诺妍, 华玲, 张瑜, 邓非, 袁月, 周军, 周红. 青蒿琥酯抑制巨噬细胞释放前炎症细胞因子的分子作用机制研究[J]. 中国临床药理学与治疗学, 2023, 28(9): 969-978.
[2]	王鑫昱, 陈亦鹏, 马永力, 何君妃. “杜仲-当归”调控NLPR3炎症小体对骨关节炎大鼠改善作用的研究[J]. 中国临床药理学与治疗学, 2023, 28(7): 751-757.
[3]	李雅亭, 岳红梅, 刘苗苗, 许金回, 武兴东, 朱浩斌. 磷酸二酯酶4抑制剂作为特发性肺纤维化药物治疗的可能性[J]. 中国临床药理学与治疗学, 2023, 28(7): 818-823.
[4]	赵灵芝, 何艳君, 谢建琴, 尤崇革. rhsTM对动脉粥样硬化的治疗作用机制研究进展[J]. 中国临床药理学与治疗学, 2023, 28(7): 832-840.
[5]	李阳, 潘维忠, 张晓录, 于翠翠. 回收式自体血回输对行剖宫产术患者免疫功能及炎症反应的影响[J]. 中国临床药理学与治疗学, 2023, 28(5): 514-524.
[6]	侯瑞英, 郭莉阁, 焦伟杰, 杜蕾, 吴桂月, 赵旭. 消渴舒方对2型糖尿病模型大鼠血清炎症因子的影响及其机制研究[J]. 中国临床药理学与治疗学, 2023, 28(4): 377-382.
[7]	李军民, 牛恒立, 谢明全, 苏金龙. 山楂黄酮抗动脉粥样硬化及降血脂作用机制研究[J]. 中国临床药理学与治疗学, 2023, 28(3): 276-282.
[8]	黄玉荣, 张红强, 游蓉丽, 贾颖, 王艳, 樊杰, 王颖莉. 青黛散外用凝胶对特异性皮炎小鼠的改善作用研究[J]. 中国临床药理学与治疗学, 2023, 28(1): 19-28.
[9]	王欣, 孙合亮, 张庆伟, 刘存明, 王忠云, 杨春. 小剂量艾司氯胺酮在胸腔镜下肺叶切除术患者术后镇痛中的作用[J]. 中国临床药理学与治疗学, 2022, 27(9): 998-1003.
[10]	毛姝英, 金蔚, 付思思, 刘珂安琪, 周志豪, 王广基, 梁艳. 口服脾多肽改善氨水诱导的小鼠咳嗽和体内炎症[J]. 中国临床药理学与治疗学, 2022, 27(6): 601-607.
[11]	金依依, 周科挺, 杨成成, 徐萍, 朱素燕. 蛇床子素抑制NF-κB和p38/MAPK改善糖尿病诱导的肾脏损伤[J]. 中国临床药理学与治疗学, 2022, 27(6): 622-631.
[12]	于泽芳, 范理菊, 尹晓玉, 高丽丽, 董占军. 新型速效抗抑郁药的研究进展[J]. 中国临床药理学与治疗学, 2022, 27(5): 595-600.
[13]	高家荣, 施苗苗, 陈浩, 姜辉, 秦秀娟. 芪藤消浊颗粒介导miR-339-5p对慢性肾小球肾炎大鼠炎症指标的影响[J]. 中国临床药理学与治疗学, 2022, 27(4): 457-465.
[14]	常书福. 冠心病药物治疗进展[J]. 中国临床药理学与治疗学, 2022, 27(4): 405-408.
[15]	王瑞杰, 王亮, 徐丹, 周淼淼, 李纪明. PCSK9抑制剂对冠心病患者血脂及炎症因子的影响[J]. 中国临床药理学与治疗学, 2022, 27(4): 409-417.

急性炎性疾病患者乳酸林格氏液液体动力学

Volume kinetics of Ringer's lactate in acute inflammatory disease

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价